News

We're investing £1.6m through our Virtual Biotech programme to drive forward the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s.

In July, we had the pleasure of hosting Membership Matters, an online event exclusively for Parkinson's UK members. We were delighted to see over 200 members sign up to either join us live or watch the recording later. 

The To be Heard! music festival supported by Parkinson’s UK showcased the creativity and achievements of people living with young onset Parkinson’s.

On 17 July, the King announced the new government's legislative programme for the next year. Here are the highlights and what it could mean for the Parkinson's community.

We wanted to make sure as many newly elected MPs understand Parkinson’s and how they can support our work to improve health care and transport services and financial support.

NHS Talking Therapies help people with their mental health. We want to hear about your experiences.

It's not just MPs who have been busy campaigning. Our local campaigners have been hard at work too. Here are some highlights of our work in England since the start of 2024.

The results found that Lee Silverman Voice Treatment (LSVT LOUD) is more effective than NHS speech and language therapy.

We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson’s.

We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson’s and to start exploring its potential benefits.